As of 2024-12-12, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 95.98 USD. This relative valuation is based on P/E multiples. With the latest stock price at 128.22 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -25.1%.
The range of the Relative Valuation is 71.69 - 125.77 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.8x - 33.0x | 30.6x |
| Forward P/E multiples | 23.6x - 38.7x | 24.8x |
| Fair Price | 71.69 - 125.77 | 95.98 |
| Upside | -44.1% - -1.9% | -25.1% |
| Date | P/E |
| 2024-12-09 | 33.88 |
| 2024-12-06 | 33.62 |
| 2024-12-05 | 33.17 |
| 2024-12-04 | 33.52 |
| 2024-12-03 | 32.91 |
| 2024-12-02 | 33.03 |
| 2024-11-29 | 33.26 |
| 2024-11-27 | 33.21 |
| 2024-11-26 | 33.56 |
| 2024-11-25 | 33.35 |
| 2024-11-22 | 32.97 |
| 2024-11-21 | 32.80 |
| 2024-11-20 | 32.35 |
| 2024-11-19 | 31.26 |
| 2024-11-18 | 30.86 |
| 2024-11-15 | 30.81 |
| 2024-11-14 | 32.24 |
| 2024-11-13 | 32.93 |
| 2024-11-12 | 33.32 |
| 2024-11-11 | 33.37 |
| 2024-11-08 | 32.99 |
| 2024-11-07 | 32.53 |
| 2024-11-06 | 32.88 |
| 2024-11-05 | 31.89 |
| 2024-11-04 | 31.62 |
| 2024-11-01 | 32.06 |
| 2024-10-31 | 31.56 |
| 2024-10-30 | 32.62 |
| 2024-10-29 | 30.49 |
| 2024-10-28 | 30.49 |
| 2024-10-25 | 30.46 |
| 2024-10-24 | 30.31 |
| 2024-10-23 | 30.19 |
| 2024-10-22 | 30.64 |
| 2024-10-21 | 30.58 |
| 2024-10-18 | 30.96 |
| 2024-10-17 | 31.08 |
| 2024-10-16 | 31.05 |
| 2024-10-15 | 30.79 |
| 2024-10-14 | 30.55 |
| 2024-10-11 | 30.30 |
| 2024-10-10 | 29.49 |
| 2024-10-09 | 29.29 |
| 2024-10-08 | 29.30 |
| 2024-10-07 | 29.43 |
| 2024-10-04 | 29.91 |
| 2024-10-03 | 29.35 |
| 2024-10-02 | 29.90 |
| 2024-10-01 | 29.95 |
| 2024-09-30 | 30.23 |